ROBERT OLADEINDE: Open Payments
NPI 1972997724 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Route 92 Medical, Inc. | 1 | $74 |
| SK Life Science, Inc. | 3 | $57 |
| Neurelis, Inc. | 2 | $49 |
| UCB, Inc. | 2 | $45 |
| Grifols USA, LLC | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: VALTOCO, Gamunex-C, Fintepla, ULTOMIRIS, Nayzilam.
Industry payments across PA — which companies pay providers there.
